BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 20339635)

  • 1. Survival and prognostic determinants of prostate cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    Beksisa J; Getinet T; Tanie S; Diribi J; Hassen HY
    PLoS One; 2020; 15(3):e0229854. PubMed ID: 32134996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary intake as a predictor for all-cause mortality in hemodialysis subjects (NUGE-HD study).
    Balbino KP; Juvanhol LL; Epifânio APS; Marota LD; Bressan J; Hermsdorff HHM
    PLoS One; 2019; 14(12):e0226568. PubMed ID: 31846484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital rectal examination and its associated factors in the early detection of prostate cancer: a cross-sectional population-based study.
    Soares SCM; de Camargo Cancela M; Migowski A; de Souza DLB
    BMC Public Health; 2019 Nov; 19(1):1573. PubMed ID: 31775710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of time valuation in cancer optimal therapies: a study of chronic myeloid leukemia.
    Gutiérrez-Diez PJ; López-Marcos MÁ; Martínez-Rodríguez J; Russo J
    Theor Biol Med Model; 2019 May; 16(1):10. PubMed ID: 31138288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System.
    Braga SFM; Souza MC; Oliveira RR; Andrade EIG; Acurcio FA; Cherchiglia ML
    Rev Saude Publica; 2017 May; 51(0):46. PubMed ID: 28538811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of prostate cancer metastasis in Afro-Brazilian men with low educational levels: a retrospective observational study.
    de Souza AB; Guedes HG; Oliveira VC; de Araújo FA; Ramos CC; Medeiros KC; Araújo RF
    BMC Public Health; 2013 Jun; 13():537. PubMed ID: 23734601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
    Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
    Ang M; Rajcic B; Foreman D; Moretti K; O'Callaghan ME
    BJU Int; 2016 Apr; 117 Suppl 4():68-75. PubMed ID: 26890320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extreme-risk prostate adenocarcinoma presenting with prostate-specific antigen (PSA)>40 ng/ml: prognostic significance of the preradiation PSA nadir.
    Alexander AS; Mydin A; Jones SO; Christie J; Lim JT; Truong PT; Ludgate CM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e713-9. PubMed ID: 21277102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy.
    Tomioka A; Tanaka N; Yoshikawa M; Miyake M; Anai S; Chihara Y; Okajima E; Hirayama A; Hirao Y; Fujimoto K
    BMC Cancer; 2015 May; 15():420. PubMed ID: 25990314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and prognostic factors of patients with clinically localized prostate cancer.
    Migowski A; Silva GA
    Rev Saude Publica; 2010 Apr; 44(2):344-52. PubMed ID: 20339635
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.